HTG Molecular Diagnostics Announces Certain Preliminary 2021Unaudited Financial Results
Preliminary full year 2021 unaudited revenue of $8.9 million Cash, cash equivalents and short-term marketable securities of $21.9 million as of December 31, 2021 TUCSON, Ariz. , Jan. 06, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose
- Category:
- Press Releases